Vise Technologies
BLTE icon

Vise Technologies’s Belite Bio BLTE Stock Holding History

Vise Technologies’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$217K Buy
+1,277
New +$207K ﹤0.01% 1934

Other funds holding BLTE

Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
High Net Worth Advisory Group
High Net Worth Advisory Group Naples, Florida $476M AUM 15.5% 1-Year Est. Return
Dymon Asia Capital (Singapore)
Dymon Asia Capital (Singapore) Singapore $2.21B AUM 109.09% 1-Year Est. Return
SmartHarvest Portfolios
SmartHarvest Portfolios Poulsbo, Washington $258M AUM 39.79% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
EverSource Wealth Advisors
EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

Vise Technologies's BLTE Position: Q3 2026 in Review

Vise Technologies opened a new position in Belite Bio (BLTE) in Q3 2026: 1,277 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #1934 among its holdings.

18 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Vise Technologies held 1,277 shares of Belite Bio worth $217K as of Q3 2026.
  • Belite Bio was a new Vise Technologies position in Q3 2026.
  • Belite Bio made up ﹤0.01% of Vise Technologies's portfolio in Q3 2026, its #1934 holding.
  • 18 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Vise Technologies's 13F filing for Q3 2026, filed 29 Oct 2026.